Valuation: Dr. Reddy's Laboratories Limited

Market Cap 946B 9.9B 8.69B 8.09B 7.44B 13.95B 14.19B 96B 37.58B 469B 37.17B 36.37B 1,621B P/E 2027 *
25.1x
P/E 2028 * 19.6x
Enterprise Value 914B 9.57B 8.4B 7.82B 7.19B 13.49B 13.72B 92.8B 36.32B 453B 35.93B 35.16B 1,567B EV / Sales 2027 *
2.6x
EV / Sales 2028 * 2.28x
Free-Float
70.08%
Yield 2027 *
0.67%
Yield 2028 * 0.74%
1 week-3.42%
Current month-15.83%
1 month-16.97%
3 months-14.10%
6 months-5.51%
Current year-10.15%
1 week 1,101
Extreme 1101
1,171.6
1 month 1,101
Extreme 1101
1,390.4
3 years 1,020
Extreme 1020
1,421.49
5 years 730.8
Extreme 730.8
1,421.49
10 years 374.59
Extreme 374.59
1,421.49
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.59%-5.84%-12.12%+2.30% 9.9B
+1.93%+3.85%+51.05%+166.24% 1,089B
+0.29%+6.43%+60.47%+52.87% 643B
+2.45%+2.77%+39.61%+74.48% 465B
-0.39%+10.17%+41.12%+35.33% 359B
-0.15%+3.80%+37.35%+42.86% 303B
+1.24%+3.20%+17.48%+17.18% 267B
+0.19%+5.21%-3.10%-38.45% 226B
+4.48%+7.33%+30.47%+66.31% 212B
+2.91%+3.10%+18.84%+74.76% 167B
Average +0.67%+5.07%+28.12%+49.39% 414.57B
Weighted average by Cap. +0.25%+5.14%+40.74%+79.58%

Financials

2027 *2028 *
Net sales 352B 3.68B 3.23B 3.01B 2.77B 5.19B 5.28B 35.71B 13.98B 175B 13.83B 13.53B 603B 393B 4.11B 3.61B 3.36B 3.09B 5.79B 5.89B 39.86B 15.6B 195B 15.43B 15.1B 673B
Net income 37.27B 390M 342M 319M 293M 550M 559M 3.78B 1.48B 18.48B 1.46B 1.43B 63.86B 49.1B 514M 451M 420M 386M 724M 737M 4.98B 1.95B 24.35B 1.93B 1.89B 84.13B
Net Debt -31.58B -331M -290M -270M -248M -466M -474M -3.21B -1.25B -15.66B -1.24B -1.21B -54.11B -51.62B -540M -474M -442M -406M -761M -774M -5.24B -2.05B -25.6B -2.03B -1.98B -88.44B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
-
Date Price Change
29/07/26 1,142.30 +0.59%
28/07/26 ₹1,135.60 -1.32%
27/07/26 ₹1,150.80 -0.08%
24/07/26 ₹1,151.70 -1.25%
23/07/26 ₹1,166.30 -1.39%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
40
Last Close Price
1,135.65INR
Average target price
1,262.63INR
Spread / Average Target
+11.18%

Quarterly revenue - Rate of surprise